Teplizumab, a new drug, could delay the need for insulin for patients with type 1 diabetes by up to 3 years.
Călin Nicolescu
Health
Foto Pixabay
Always see our news on Google
Teplizumab, a drug already approved in the US, is being tested in the UK to slow the progression of type 1 diabetes by training the immune system to protect pancreatic cells. Hannah Robinson, the first British adult to receive the treatment, hopes it will delay the need for insulin. Experts believe the treatment represents a major change in diabetes management, with the potential to alter the immune process and help high-risk people avoid insulin therapy.
Sources
Un medicament "revoluţionar" ar putea încetini evoluţia diabetului de tip 1. Poate întârzia nevoia de insulină cu 3 ani
Devon mother treated with game-changing diabetes drug
Mother of two becomes the first UK patient to receive ‘groundbreaking’ new diabetes drug
Un medicament „revoluționar”, o nouă speranță pentru diabetul de tip 1. Ce așteptări au medicii
Latest News
14:04
EXCLUSIV E-TRENDS by NewsVibe. Topul temelor economice în tendințe, în ultima săptămână
13:46
Netflix, sued for 105 million dollars after the disappearance of a copy of the movie "Fortitude," starring Nicolas Cage
13:41
Starting August 1, Bulgaria will increase the price of vehicle stickers by 30%, including fines for driving without a sticker.
13:39
The Dormition Fast of the Mother of God began on July 31 and will end on August 14. It is recommended to read the Akathist of the Mother of God and specific dietary rules are observed.
13:33
Herastrau Park will benefit from private investments of 900,000 euros for rehabilitation.
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
